Stereotactically guided conformal radiotherapy for meningiomas

H. Alheit, F. H. Saran, A. P. Warrington, I. Rosenberg, Julian R Perks, R. Jalali, S. Shepherd, C. Beardmore, B. Baumert, M. Brada

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose: Stereotactically guided conformal radiotherapy, (SCRT) is a high precision technique of conformal radiotherapy (RT) which reduces the volume of normal tissue irradiated compared to conventional RT and may lead to a reduction in long-term toxicity we describe the technique and the preliminary results in patients with inoperable, residual or recurrent meningiomas. Material and methods: From July 1993 to November 1997, 24 patients (median age: 56 years, range: 28-72) with base of skull (n = 21), falx or upper skull (n = 3) meningiomas were treated with SCRT. The technique employed immobilization in a Gill-Thomas-Cosman (GTC) frame and CT localization with a Brown-Roberts-Wells (BRW) fiducial system for stereotactic space definition. The planning target volume (PTV) was defined as gross tumour volume (GTV) and a 0.5-1 cm margin. Treatment was delivered with three (12 patients) or four noncoplanar conformal fixed fields (12 patients) Conformal blocking was achieved either with lead alloy blocks (n = 11) or with a multi-leaf collimator (MLC) (n = 13). Patients were treated on a 6 MV linear accelerator to doses of 50-55 Gy, in 30-33 daily fractions. The treatments were carried out as part of a routine work of a busy radiotherapy department. Results: Median GTV for 24 meningiomas was 21.7 cm3 (range: 4.4- 183 cm3). SCRT was well tolerated with minimal toxicity Three months after the end of radiotherapy, seven of 15 patients with neurological deficit had an improvement and eight remained unchanged. Two patients experienced early side effects (one VII nerve palsy, one Addisonian state). At a median follow- up of 13-months (range: 3-43) the 1 year progression free survival and overall survival are 100%, which is within the range expected for conventional fractionated radiotherapy for meningiomas. Conclusions: SCRT is a feasible technique of high precision conformal RT for patients with meningiomas. Potential advantages in tumour control, survival and toxicity over conventional RT, require evaluation in long-term prospective studies.

Original languageEnglish (US)
Pages (from-to)145-150
Number of pages6
JournalRadiotherapy and Oncology
Volume50
Issue number2
DOIs
StatePublished - Feb 1 1999
Externally publishedYes

Fingerprint

Conformal Radiotherapy
Meningioma
Radiotherapy
Tumor Burden
Particle Accelerators
Survival
Skull Base
Facial Nerve
Skull
Paralysis
Immobilization
Disease-Free Survival
Prospective Studies

Keywords

  • 3-D planning
  • Meningioma
  • Stereotactic conformal radiotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Cite this

Alheit, H., Saran, F. H., Warrington, A. P., Rosenberg, I., Perks, J. R., Jalali, R., ... Brada, M. (1999). Stereotactically guided conformal radiotherapy for meningiomas. Radiotherapy and Oncology, 50(2), 145-150. https://doi.org/10.1016/S0167-8140(98)00133-9

Stereotactically guided conformal radiotherapy for meningiomas. / Alheit, H.; Saran, F. H.; Warrington, A. P.; Rosenberg, I.; Perks, Julian R; Jalali, R.; Shepherd, S.; Beardmore, C.; Baumert, B.; Brada, M.

In: Radiotherapy and Oncology, Vol. 50, No. 2, 01.02.1999, p. 145-150.

Research output: Contribution to journalArticle

Alheit, H, Saran, FH, Warrington, AP, Rosenberg, I, Perks, JR, Jalali, R, Shepherd, S, Beardmore, C, Baumert, B & Brada, M 1999, 'Stereotactically guided conformal radiotherapy for meningiomas', Radiotherapy and Oncology, vol. 50, no. 2, pp. 145-150. https://doi.org/10.1016/S0167-8140(98)00133-9
Alheit, H. ; Saran, F. H. ; Warrington, A. P. ; Rosenberg, I. ; Perks, Julian R ; Jalali, R. ; Shepherd, S. ; Beardmore, C. ; Baumert, B. ; Brada, M. / Stereotactically guided conformal radiotherapy for meningiomas. In: Radiotherapy and Oncology. 1999 ; Vol. 50, No. 2. pp. 145-150.
@article{c74cb887c9cd47b18525c943929a6eaa,
title = "Stereotactically guided conformal radiotherapy for meningiomas",
abstract = "Purpose: Stereotactically guided conformal radiotherapy, (SCRT) is a high precision technique of conformal radiotherapy (RT) which reduces the volume of normal tissue irradiated compared to conventional RT and may lead to a reduction in long-term toxicity we describe the technique and the preliminary results in patients with inoperable, residual or recurrent meningiomas. Material and methods: From July 1993 to November 1997, 24 patients (median age: 56 years, range: 28-72) with base of skull (n = 21), falx or upper skull (n = 3) meningiomas were treated with SCRT. The technique employed immobilization in a Gill-Thomas-Cosman (GTC) frame and CT localization with a Brown-Roberts-Wells (BRW) fiducial system for stereotactic space definition. The planning target volume (PTV) was defined as gross tumour volume (GTV) and a 0.5-1 cm margin. Treatment was delivered with three (12 patients) or four noncoplanar conformal fixed fields (12 patients) Conformal blocking was achieved either with lead alloy blocks (n = 11) or with a multi-leaf collimator (MLC) (n = 13). Patients were treated on a 6 MV linear accelerator to doses of 50-55 Gy, in 30-33 daily fractions. The treatments were carried out as part of a routine work of a busy radiotherapy department. Results: Median GTV for 24 meningiomas was 21.7 cm3 (range: 4.4- 183 cm3). SCRT was well tolerated with minimal toxicity Three months after the end of radiotherapy, seven of 15 patients with neurological deficit had an improvement and eight remained unchanged. Two patients experienced early side effects (one VII nerve palsy, one Addisonian state). At a median follow- up of 13-months (range: 3-43) the 1 year progression free survival and overall survival are 100{\%}, which is within the range expected for conventional fractionated radiotherapy for meningiomas. Conclusions: SCRT is a feasible technique of high precision conformal RT for patients with meningiomas. Potential advantages in tumour control, survival and toxicity over conventional RT, require evaluation in long-term prospective studies.",
keywords = "3-D planning, Meningioma, Stereotactic conformal radiotherapy",
author = "H. Alheit and Saran, {F. H.} and Warrington, {A. P.} and I. Rosenberg and Perks, {Julian R} and R. Jalali and S. Shepherd and C. Beardmore and B. Baumert and M. Brada",
year = "1999",
month = "2",
day = "1",
doi = "10.1016/S0167-8140(98)00133-9",
language = "English (US)",
volume = "50",
pages = "145--150",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Stereotactically guided conformal radiotherapy for meningiomas

AU - Alheit, H.

AU - Saran, F. H.

AU - Warrington, A. P.

AU - Rosenberg, I.

AU - Perks, Julian R

AU - Jalali, R.

AU - Shepherd, S.

AU - Beardmore, C.

AU - Baumert, B.

AU - Brada, M.

PY - 1999/2/1

Y1 - 1999/2/1

N2 - Purpose: Stereotactically guided conformal radiotherapy, (SCRT) is a high precision technique of conformal radiotherapy (RT) which reduces the volume of normal tissue irradiated compared to conventional RT and may lead to a reduction in long-term toxicity we describe the technique and the preliminary results in patients with inoperable, residual or recurrent meningiomas. Material and methods: From July 1993 to November 1997, 24 patients (median age: 56 years, range: 28-72) with base of skull (n = 21), falx or upper skull (n = 3) meningiomas were treated with SCRT. The technique employed immobilization in a Gill-Thomas-Cosman (GTC) frame and CT localization with a Brown-Roberts-Wells (BRW) fiducial system for stereotactic space definition. The planning target volume (PTV) was defined as gross tumour volume (GTV) and a 0.5-1 cm margin. Treatment was delivered with three (12 patients) or four noncoplanar conformal fixed fields (12 patients) Conformal blocking was achieved either with lead alloy blocks (n = 11) or with a multi-leaf collimator (MLC) (n = 13). Patients were treated on a 6 MV linear accelerator to doses of 50-55 Gy, in 30-33 daily fractions. The treatments were carried out as part of a routine work of a busy radiotherapy department. Results: Median GTV for 24 meningiomas was 21.7 cm3 (range: 4.4- 183 cm3). SCRT was well tolerated with minimal toxicity Three months after the end of radiotherapy, seven of 15 patients with neurological deficit had an improvement and eight remained unchanged. Two patients experienced early side effects (one VII nerve palsy, one Addisonian state). At a median follow- up of 13-months (range: 3-43) the 1 year progression free survival and overall survival are 100%, which is within the range expected for conventional fractionated radiotherapy for meningiomas. Conclusions: SCRT is a feasible technique of high precision conformal RT for patients with meningiomas. Potential advantages in tumour control, survival and toxicity over conventional RT, require evaluation in long-term prospective studies.

AB - Purpose: Stereotactically guided conformal radiotherapy, (SCRT) is a high precision technique of conformal radiotherapy (RT) which reduces the volume of normal tissue irradiated compared to conventional RT and may lead to a reduction in long-term toxicity we describe the technique and the preliminary results in patients with inoperable, residual or recurrent meningiomas. Material and methods: From July 1993 to November 1997, 24 patients (median age: 56 years, range: 28-72) with base of skull (n = 21), falx or upper skull (n = 3) meningiomas were treated with SCRT. The technique employed immobilization in a Gill-Thomas-Cosman (GTC) frame and CT localization with a Brown-Roberts-Wells (BRW) fiducial system for stereotactic space definition. The planning target volume (PTV) was defined as gross tumour volume (GTV) and a 0.5-1 cm margin. Treatment was delivered with three (12 patients) or four noncoplanar conformal fixed fields (12 patients) Conformal blocking was achieved either with lead alloy blocks (n = 11) or with a multi-leaf collimator (MLC) (n = 13). Patients were treated on a 6 MV linear accelerator to doses of 50-55 Gy, in 30-33 daily fractions. The treatments were carried out as part of a routine work of a busy radiotherapy department. Results: Median GTV for 24 meningiomas was 21.7 cm3 (range: 4.4- 183 cm3). SCRT was well tolerated with minimal toxicity Three months after the end of radiotherapy, seven of 15 patients with neurological deficit had an improvement and eight remained unchanged. Two patients experienced early side effects (one VII nerve palsy, one Addisonian state). At a median follow- up of 13-months (range: 3-43) the 1 year progression free survival and overall survival are 100%, which is within the range expected for conventional fractionated radiotherapy for meningiomas. Conclusions: SCRT is a feasible technique of high precision conformal RT for patients with meningiomas. Potential advantages in tumour control, survival and toxicity over conventional RT, require evaluation in long-term prospective studies.

KW - 3-D planning

KW - Meningioma

KW - Stereotactic conformal radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0032945626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032945626&partnerID=8YFLogxK

U2 - 10.1016/S0167-8140(98)00133-9

DO - 10.1016/S0167-8140(98)00133-9

M3 - Article

C2 - 10368037

AN - SCOPUS:0032945626

VL - 50

SP - 145

EP - 150

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 2

ER -